Ophthalmology
News, opinions and meeting coverage in ophthalmology.
β In the third year, 88% of patients could go 12 weeks or longer with 8-mg dose
Latest in Ophthalmology
Ophthalmologists say findings emphasize the importance of adhering to medication regimens
Delegates express concerns that PPE doesn't always cover women, who are more at risk of exposure
Peter K. Kaiser, MD, leads a discussion about the presentation given by Yasha S. Modi, MD, at AAO
Members also debate alternative ways states can safely license foreign med-school graduates
Peter K. Kaiser, MD, leads a discussion about the presentation given by Yasha S. Modi, MD, at AAO
Members also debate alternative ways states can safely license foreign med-school graduates
Ophthalmology Case Studies
Tropical parasitic disease is often asymptomatic, but beware of unexplained ocular symptoms
Case highlights risk-benefit considerations with concurrent bilateral intravitreal injections
Authors discuss how best to diagnose and manage him, given the absence of any symptoms
More in Ophthalmology
Ophthalmologists hope expanded use will lead to more evaluations in primary clinics
Valeda photobiomodulation system slowed disease progression and improved vision
Peter K. Kaiser, MD, leads a discussion from the AAO meeting
Retired physician Jay Berger, MD, reportedly suffered a mental health crisis
Provision in drug act would prohibit repackaging Avastin, add millions to anti-VEGF therapy cost
Significant improvement beyond 100 weeks after single injection of mutation-agnostic MCO-010
Office procedure reduced visual field loss by 29% over 6 years versus eye drops
Three cycles could become the new standard for retinoblastoma, researchers say
Drug targeting junctional zone reduces GA growth by 48% in 3 months, oral agent moderately active
Study suggests potential to eliminate a third of in-office visits without harming care
Study adds leg and ankle fractures, intracranial hemorrhage to evidence on falls, hip fracture
History of injections tied to multiple postop complications, but data open to questioning
Black adults roughly twice as likely as white adults to be affected
After faricimab injections, two eyes had retinal vasculitis, one with significant vision loss
